Webinars

MDoutlook® Delivers Precision Intelligence

No post found
MDoutlook celebrates its 8th consecutive year of syndicated research gauging the clinical impact of new data presented at ASCO 2015. Building on over 30 analyses since 2008, MDoutlook today releases the first analysis in a new series covering solid and liquid tumors. This OncoPoll™ focuses on the continued evolution of
Read more
Since 2008, MDoutlook has built the largest panel of cancer treaters in the world. With more than 85,000 cancer treaters verified and profiled, MDoutlook uniquely identifies and targets oncologists and other physicians dedicated to the management of cancer. MDoutlook has developed a suite of offerings built on this proprietary oncology
Read more
Built upon years of experience and appreciating the multi-factorial complexity of identifying and engaging ThoughtLeaders, MDoutlook has developed robust algorithms to capture all attributes of a ThoughtLeader's impact on the market. MDoutlook delivers 360° profiles of identified ThoughtLeaders, uniquely meshing public and proprietary data. Through our exclusive ThoughtLeader Attribute Dial™,
Read more
MDoutlook supports dozens of clients in understanding the real changes in clinical practice. Driven by a proven methodology, engaging proprietary panels of validated and qualified healthcare providers, our team delivers meaningful insights to life science clients: from large to small, from mainstream pharma to biotech, and from medicine to technology
Read more
Much improvement has been made in the diagnosis and treatment of cancer. However, with ever increasing insight it is also clear that much more needs to be done. Many of these things are within our own hands and actions. Here is a link to an interesting article from NPR with
Read more
MDoutlook is growing and is looking for qualified Global Medical Analysts to join our enthusiastic team of disease experts. You can review the job posting here. Direct your resume and cover letter to [email protected] (only candidates; no recruiters please). Looking forward to hearing from you.
Read more
MDoutlook continues delivering timely post-conference insight through the Post-SABCS2014 OncoPoll™ - but with a new dimension this year. The syndicated MDoutlook post-SABCS2014 analysis focuses on breast cancer therapeutic areas where much new data was presented: new agents, adjuvant & metastatic therapy, and the emerging likelihood of biosimilars used for supportive
Read more
MDoutlook continues its tradition of delivering timely post-conference insight through a series of 3 Post-ASH OncoPolls™ - but with a new dimension. The syndicated MDoutlook post-ASH2014 analysis focuses on three disease areas where much new data was presented (CLL and ALL, as well as Multiple Myeloma). To insure timely intelligence
Read more